Telomere length and aging-related outcomes in humans: A Mendelian randomization study in 261,000 older participants.


Journal

Aging cell
ISSN: 1474-9726
Titre abrégé: Aging Cell
Pays: England
ID NLM: 101130839

Informations de publication

Date de publication:
12 2019
Historique:
received: 29 11 2018
revised: 04 07 2019
accepted: 06 07 2019
pubmed: 25 8 2019
medline: 15 9 2020
entrez: 25 8 2019
Statut: ppublish

Résumé

Inherited genetic variation influencing leukocyte telomere length provides a natural experiment for testing associations with health outcomes, more robust to confounding and reverse causation than observational studies. We tested associations between genetically determined telomere length and aging-related health outcomes in a large European ancestry older cohort. Data were from n = 379,758 UK Biobank participants aged 40-70, followed up for mean of 7.5 years (n = 261,837 participants aged 60 and older by end of follow-up). Thirteen variants strongly associated with longer telomere length in peripheral white blood cells were analyzed using Mendelian randomization methods with Egger plots to assess pleiotropy. Variants in TERC, TERT, NAF1, OBFC1, and RTEL1 were included, and estimates were per 250 base pairs increase in telomere length, approximately equivalent to the average change over a decade in the general white population. We highlighted associations with false discovery rate-adjusted p-values smaller than .05. Genetically determined longer telomere length was associated with lowered risk of coronary heart disease (CHD; OR = 0.95, 95% CI: 0.92-0.98) but raised risk of cancer (OR = 1.11, 95% CI: 1.06-1.16). Little evidence for associations were found with parental lifespan, centenarian status of parents, cognitive function, grip strength, sarcopenia, or falls. The results for those aged 60 and older were similar in younger or all participants. Genetically determined telomere length was associated with increased risk of cancer and reduced risk of CHD but little change in other age-related health outcomes. Telomere lengthening may offer little gain in later-life health status and face increasing cancer risks.

Identifiants

pubmed: 31444995
doi: 10.1111/acel.13017
pmc: PMC6826144
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13017

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : NIA NIH HHS
Pays : United States

Informations de copyright

© 2019 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.

Références

J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1453-1464
pubmed: 28329165
BMJ. 2018 Jul 12;362:k601
pubmed: 30002074
J Gerontol A Biol Sci Med Sci. 2019 Mar 14;74(4):582-587
pubmed: 29924297
Cancer Epidemiol Biomarkers Prev. 2017 Sep;26(9):1381-1390
pubmed: 28619828
Trends Genet. 2013 Sep;29(9):513-20
pubmed: 23876621
Hum Mol Genet. 2012 Dec 15;21(24):5385-94
pubmed: 23001564
Eur J Hum Genet. 2013 Oct;21(10):1163-8
pubmed: 23321625
Nat Genet. 2013 Apr;45(4):422-7, 427e1-2
pubmed: 23535734
Nat Commun. 2013;4:1597
pubmed: 23511462
JAMA Neurol. 2015 Oct;72(10):1202-3
pubmed: 26457630
EMBO J. 2019 Mar 1;38(5):
pubmed: 30737259
Genet Epidemiol. 2013 Nov;37(7):658-65
pubmed: 24114802
Exp Gerontol. 2016 Sep;82:88-94
pubmed: 27321645
Arch Neurol. 2010 Jul;67(7):876-80
pubmed: 20625097
BMJ. 2014 Jul 08;349:g4227
pubmed: 25006006
JAMA Oncol. 2017 May 1;3(5):636-651
pubmed: 28241208
Int J Epidemiol. 2013 Oct;42(5):1497-501
pubmed: 24159078
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Haematologica. 2017 Aug;102(8):1457-1465
pubmed: 28522577
PLoS Med. 2016 Nov 29;13(11):e1002188
pubmed: 27898678
Int J Epidemiol. 2015 Apr;44(2):512-25
pubmed: 26050253
Oncogene. 2002 Jan 21;21(4):564-79
pubmed: 11850781
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
J Gerontol A Biol Sci Med Sci. 2018 Nov 10;73(12):1626-1632
pubmed: 29346517
Hum Mol Genet. 2014 Sep 15;23(R1):R89-98
pubmed: 25064373
Int J Epidemiol. 2017 Dec 1;46(6):1734-1739
pubmed: 28398548
Epidemiol Rev. 2013;35:112-31
pubmed: 23302541
J Bone Miner Res. 2009 Sep;24(9):1531-6
pubmed: 19338455
Aging (Albany NY). 2017 Dec 6;9(12):2504-2520
pubmed: 29227965
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Am J Epidemiol. 2017 Nov 1;186(9):1026-1034
pubmed: 28641372
Philos Trans R Soc Lond B Biol Sci. 2018 Mar 5;373(1741):
pubmed: 29335375
Science. 2015 Dec 4;350(6265):1193-8
pubmed: 26785477
Age Ageing. 2011 Jul;40(4):494-500
pubmed: 21622673
Nurs Res. 2014 Jan-Feb;63(1):36-50
pubmed: 24335912
Int J Epidemiol. 2018 Feb 1;47(1):226-235
pubmed: 29040562
J Gerontol A Biol Sci Med Sci. 2011 Feb;66(2):202-13
pubmed: 21030466
J Pain. 2017 Dec;18(12):1517-1525
pubmed: 28919432
Exp Gerontol. 2018 Jun;106:16-20
pubmed: 29518479
Aging Cell. 2019 Dec;18(6):e13017
pubmed: 31444995
Bioinformatics. 2015 Nov 1;31(21):3555-7
pubmed: 26139635
Bioinformatics. 2010 Nov 15;26(22):2867-73
pubmed: 20926424
J Appl Physiol (1985). 2000 Aug;89(2):465-71
pubmed: 10926627
Exp Cell Res. 1961 Dec;25:585-621
pubmed: 13905658
J Gerontol A Biol Sci Med Sci. 2013 Nov;68(11):1409-18
pubmed: 23685624
Biogerontology. 2018 Jul;19(3-4):209-221
pubmed: 29549539

Auteurs

Chia-Ling Kuo (CL)

Department of Community Medicine and Health Care, Connecticut Convergence Institute for Translation in Regenerative Engineering, Institute for Systems Genomics, University of Connecticut Health, Farmington, CT, USA.

Luke C Pilling (LC)

Epidemiology and Public Health Group, University of Exeter Medical School, RILD Level 3, Royal Devon & Exeter Hospital, Exeter, UK.

George A Kuchel (GA)

Center on Aging, School of Medicine, University of Connecticut, Farmington, CT, USA.

Luigi Ferrucci (L)

National Institute on Aging, Baltimore, MD, USA.

David Melzer (D)

Epidemiology and Public Health Group, University of Exeter Medical School, RILD Level 3, Royal Devon & Exeter Hospital, Exeter, UK.
Center on Aging, School of Medicine, University of Connecticut, Farmington, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH